Cadonilimab (Anti-PD-1 & CTLA-4)
Product Specifications
CAS Number
2394841-59-7
Synonyms
AK104
SKU
C00868-1mg
Target
PD-1/PD-L1
Applications
Apoptosis
Additionnal Information
Cadonilimab is a humanized tetravalent bispecific IgG1 antibody targeting human PD-1 and CTLA-4 with potential immune checkpoint inhibitory and antineoplastic activities. It has the potential to treat recurrent or metastatic cervical cancer. MW : 198.64 KD.
Storage Conditions
-80°C (avoid freeze-thaw cycles)
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog